`Going After Big Pharma And Its 'BS
`Patents'
`
`JULIA LA ROCHE
`JAN. 7, 2015, 10:47 AM
`
`Texan hedge fund manager Kyle
`Bass is going activist against the US
`pharmaceutical industry and its
`patents, according to a conference
`attendee on Twitter.
`
`"We'll have a separate pharmacy
`vehicle. We've dedicated half of our
`resources over the past six months
`to this," Bass told conference
`attendees.
`
`According to the conference
`attendee, Bass called it a "short
`activist strategy."
`
`Bass, the founder of Hayman Capital,
`was speaking at the Skagen New
`Year's Conference in Copenhagen.
`His presentation was titled "The US
`Has A Drug Problem."
`
`REUTERS/Brendan McDermid
`Kyle Bass, founder and principal of Hayman Capital
`Management LP, at the Sohn Investment
`Conference in New York on May 8, 2013.
`
`Bass told conference attendees that
`"pay for delay" is coming to an end for drugmakers. He also said he planned to file IPR petitions
`(inter partes reviews) to challenge drugmaker patents.
`
`"This will change the way pharma companies [manage] their BS patents," Bass said.
`
`He continued: "The beautiful thing is this will lower drug prices for everyone."
`
`We reached out to Hayman Capital for more on the presentation.
`
`NOW WATCH: Here's How 2 Dudes Make More Than $4 Million A
`Year On YouTube
`
`Kyle Bass going after US pharma Business Insider
`
`http://www.businessinsider.com/kylebassgoingafteruspharma20151
`
`1/2
`
`Page 1 of 2
`
`CELGENE EXHIBIT 2029
`Coalition for Affordable Drugs VI LLC (Petitioner) v. Celgene Corporation (Patent Owner)
`Case IPR2015-01103
`
`
`
`
`
`* Copyright © 2015 Business Insider Inc. All rights reserved.
`
`Kyle Bass going after US pharma Business Insider
`
`http://www.businessinsider.com/kylebassgoingafteruspharma20151
`
`2/2
`
`Page 2 of 2